These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Preparation and characterization of Pertussis toxin subunits. Sheu GC, Wo YY, Lu CH. Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1997 Aug; 30(3):182-93. PubMed ID: 10592823 [Abstract] [Full Text] [Related]
25. Expression of a pertussis toxin S1 fragment by inducible promoters in oral Streptococcus and the induction of immune responses during oral colonization in mice. Mallaley PP, Halperin SA, Morris A, MacMillan A, Lee SF. Can J Microbiol; 2006 May; 52(5):436-44. PubMed ID: 16699568 [Abstract] [Full Text] [Related]
26. Pertussis toxin analog with reduced enzymatic and biological activities is a protective immunogen. Kimura A, Mountzouros KT, Schad PA, Cieplak W, Cowell JL. Infect Immun; 1990 Oct; 58(10):3337-47. PubMed ID: 2119344 [Abstract] [Full Text] [Related]
27. Immune response to dimeric subunits of the pertussis toxin B oligomer. Hausman SZ, Burns DL, Sickler VC, Manclark CR. Infect Immun; 1989 Jun; 57(6):1760-4. PubMed ID: 2722238 [Abstract] [Full Text] [Related]
33. Recombinant acellular pertussis vaccine--from the laboratory to the clinic: improving the quality of the immune response. Rappuoli R, Pizza M, Covacci A, Bartoloni A, Nencioni L, Podda A, De Magistris MT. FEMS Microbiol Immunol; 1992 Oct; 5(4):161-70. PubMed ID: 1384602 [Abstract] [Full Text] [Related]
35. [A polyvalent complex of Bordetella pertussis antigens as the basis for an acellular pertussis vaccine]. Zakharova NS, Shmeleva EI, Remova TN, Bazhanova IG, Ozeretskovskaia MN, Mertsalova NU, Britsina MV, Ermolova EV, Zaĭtsev EM. Zh Mikrobiol Epidemiol Immunobiol; 1997 Oct; (3):70-2. PubMed ID: 9304336 [Abstract] [Full Text] [Related]
36. Neutralizing antibodies and immunoprotection against pertussis and tetanus obtained by use of a recombinant pertussis toxin-tetanus toxin fusion protein. Boucher P, Sato H, Sato Y, Locht C. Infect Immun; 1994 Feb; 62(2):449-56. PubMed ID: 7507893 [Abstract] [Full Text] [Related]
37. Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant. Isaka M, Yasuda Y, Taniguchi T, Kozuka S, Matano K, Maeyama J, Morokuma K, Ohkuma K, Goto N, Tochikubo K. Vaccine; 2003 Mar 07; 21(11-12):1165-73. PubMed ID: 12559794 [Abstract] [Full Text] [Related]
38. [Cellular and acellular anti-pertussis vaccines]. Locht C. Ann Pharm Fr; 2001 May 07; 59(3):198-205. PubMed ID: 11427821 [Abstract] [Full Text] [Related]
39. Evaluation of antibodies elicited by immunization with pertussis toxin. Kaslow HR, Schlotterbeck JD, Gotto J. Dev Biol Stand; 1991 May 07; 73():143-50. PubMed ID: 1778308 [Abstract] [Full Text] [Related]